Market Signal Briefing

The network’s native token, ADA, dropped 3% over the past 24 hours as selling pressure mounted and altcoin rotation gained pace. Oct 29, 2025, 3:29 p.m.

Cardano’s native token, ADA, fell sharply Wednesday, dropping over 3% to 64 cents as it broke through a critical support level and confirmed a shift in market sentiment, CoinDesk Analytics data found.

The breakdown began Tuesday, when trading volume spiked 67% above its 24-hour average. Nearly 183 million tokens changed hands as ADA slipped below 64.5 cents, triggering sales and setting off a move toward lower support zones.

The move reflected growing uncertainty in altcoin markets as institutional flows turned negative. According to CoinShares, ADA saw $300,000 in outflows this week, following $3.7 million in inflows from the prior week. Analysts point to delays in crypto ETF approvals and broader risk-off behavior as key reasons for the rotation out of altcoins and into more stable assets.

Technical indicators now show strong resistance at 65.50 cents, with ADA’s recent lower highs from the 67.19 cent peak reinforcing a bearish trend. Unless buyers reclaim that resistance, analysts say the token could retest the 64 cent level, with further downside possible.

The broader crypto market also stumbled. CoinDesk’s CD5 index dropped 2% in the past 24 hours, underlining continued pressure across digital assets heading into the final months of the year.

Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.

More For You

OwlTing: Stablecoin Infrastructure for the Future

Stablecoin payment volumes have grown to $19.4B year-to-date in 2025. OwlTing aims to capture this market by developing payment infrastructure that processes transactions in seconds for fractions of a cent.

View Full Report

More For You

Michael Saylor's Strategy Drops $18B in Value, but a Rebound May Be Near: 10X Research

The company is expected to report another quarterly profit on Thursday, possibly reviving expectations for S&P 500 inclusion, 10x Research's Markus Thielen argued.

What to know:

Bitcoin treasury firm Strategy (MSTR) has slumped 40% since July, but a potential rebound nears with upcoming catalysts, 10x Research's Markus Thielen said.Thielen expects the company to report a third quarter $3.6 billion profit from BTC mark-to-market gains, reviving speculation about S&P 500 inclusion.Inclusion in the index could mean $28 billion of buying pressure on the stock, said Thielen.Read full story

At a Glance

The GENIUS Act in the U.S. gave private stablecoin issuers a legal framework while stalling a government issued CBDC.
Tether, issuer of USDT, earned record profits and became one of the largest private holders of U.S. Treasuries.
The company’s cooperation with regulators and law-enforcement shows how stablecoins function as compliance rails, not as alternatives to them.
Many Bitcoin advocates now align with Tether’s ecosystem, unintentionally helping extend the fiat system they claim to resist.

Bitcoin’s Quiet Compromise
When the GENIUS Act became law on 18 July 2025, the crypto industry celebrated it as the end of regulatory uncertainty. The Act requires licensed stablecoin issuers to hold liquid reserves such as cash and U.S. Treasuries, publish monthly disclosures, and submit to federal or state supervision. At the same time, Congress shelved a federal central bank digital currency.

Supporters saw this as a victory for innovation, but critics called it a quiet federalization of private money. The United States no longer needs to issue its own digital dollar. It has simply delegated that function to private issuers operating under oversight. For Bitcoiners, whose movement was built around sound, decentralised money, that shift should have triggered alarm bells.

Tether’s Private Empire
The biggest beneficiary of this new framework is Tether Limited, whose USDT token dominates global stablecoin supply. In its Q2 2025 attestation, Tether Limited reported a net profit of approximately $4.9 billion and total exposure to U.S. Treasuries exceeding $127 billion. Treasury bills and reverse repo holdings. Its balance sheet showed nearly $120 billion in Treasuries, making Tether one of the world’s largest private holders of U.S. government debt.

Custody of those assets rests with Cantor Fitzgerald, the Wall Street firm led by Howard Lutnick. Lutnick has publicly defended the soundness of Tether’s reserves, confirming Cantor’s role as custodian while emphasising that it holds no equity stake in the company. 

The connection is now more delicate: Lutnick was later nominated for a senior White House economic position overseeing elements of trade and financial regulation. That appointment places a federal policymaker in proximity to one of the largest private holders of U.S. government debt and the key custodian for a company whose dollar backed token depends on the U.S. Treasuries for profit. The optics are uncomfortable. What began as a business relationship now blurs into a potential conflict of interest, embedding Tether in Wall Street’s plumbing and within the political apparatus that governs it.

In effect, Tether has become a private central bank: issuing dollar liabilities, earning seigniorage, and distributing liquidity through the crypto economy, all while piggy backing on U.S. sovereign debt. Its profit per employee rivals the most profitable institutions in finance.

Surveillance by Proxy
Stablecoins promise fast, borderless payments; however, their architecture depends on compliance. Since December 2023, Tether has maintained a proactive wallet-freezing policy for addresses sanctioned by the U.S. Office of Foreign Assets Control. The company says it has frozen billions in tokens linked to illicit activity and now works directly with the U.S. Secret Service and FBI. 

This is not inherently sinister, it’s what regulators demand, but it means enforcement now operates within the money itself. The control lever no longer sits solely with banks, it resides in the smart contract of the token issuer.

As Tether expands USDT onto Bitcoin adjacent networks such as Liquid and the RGB protocol, the same compliance logic will travel with it. The more Bitcoin infrastructure hosts these tokens, the more identity, KYC, and whitelisting mechanisms will appear around Bitcoin wallets and payment channels. The network that once prided itself on neutrality risks becoming a conduit for surveillance grade rails.

The Political Economy of the Digital Dollar
The GENIUS Act’s passage also realigned the politics of digital currency. Its sponsors framed it as an anti-CBDC measure, arguing that private stablecoins preserve choice and limit government power. However, the result is nearly identical to what a central bank digital currency would achieve: programmable, trackable dollars, only administered by corporations instead of the Fed. Some analysts have called this the birth of a “CBDC by proxy.“

The policy also meshes neatly with fiscal priorities. Every USDT minted represents demand for short dated Treasuries, effectively financing the same government that stablecoin advocates claim to bypass. Tether’s profits flow from the interest rate paid on those securities, an invisible subsidy from public debt to private issuers.

By situating stablecoins within the traditional bond market, the U.S. has created a dollar based feedback loop: bitcoin demand supports Treasury issuance, and Treasury yields support bitcoin profitability. In that loop, decentralization is incidental.

Co-opting the Bitcoin Narrative
Within the Bitcoin community, opposition to altcoins remains strong, but sponsorships, event partnerships, and integrations show how quickly principle bends toward funding. Bitcoin conferences increasingly feature Tether executives and supporters on stage, often framed as “bridges” to adoption. 

A familiar refrain has emerged among those bitcoiners who take money from Tether,  ‘if stablecoins are inevitable, it’s better they be run by Bitcoiners’. Another popular defence is that Tether provides a lifeline for people in countries locked out of the dollar system or suffering from hyperinflation and collapsing economies. This is an emotionally persuasive narrative.  These convenient mantras turn compromise into virtue, allowing Bitcoiners to take sponsorships and funding from the same system they once swore to oppose.

That logic may offer comfort to some, but erodes clarity. USDT on Bitcoin does not make Bitcoin more sovereign; it makes the dollar more omnipresent. When Bitcoin developers or advocates align with Tether for sponsorship or exposure, they lend moral legitimacy to a system that thrives on fiat’s dominance. The irony is that Bitcoin’s fiercest defenders are now helping entrench the very structure it was built to escape.

Follow the Money
Tether’s scale gives it power in markets and in messaging. With billions in annual profits and deep links to Wall Street custodians, it can sponsor conferences, fund research, and influence narratives across the digital asset world. Its executives appear frequently at policy forums to present stablecoins as allies of innovation and freedom. Each appearance helps normalise the idea that regulated, dollar denominated tokens represent progress for Bitcoin.

But the money tells a different story. Each stablecoin transaction that settles in USDT extends the dollar system’s reach and perpetuates the weaponization of money. Every layer of compliance embeds surveillance deeper into the blockchain economy. And every Bitcoiner who accepts that trade off helps build a network where decentralization endures mostly as branding.

Bitcoin doesn’t need a conspiracy against it; it only needs its followers to forget what made it different. The GENIUS Act, the rise of Tether, and the regulatory preference for private rails all point to a future where digital cash exists, but never without permission. The Trojan horse is not Tether, it’s the belief that working with it preserves freedom.

In the end, too many Bitcoiners remain exactly where Tether wants them, still tethered to the system they are trying to escape.

Plain Memo

Plain Memo is an anonymous contributor from the Bitcoin space.

TL;DR:

Ethereum launches “Ethereum for Institutions” to guide enterprise adoption.
L2 ecosystem exceeds $50B, offering scalability and compliance tools.
Institutional adoption accelerates with case studies, analytics, and enterprise-grade infrastructure.

The Ethereum Foundation has unveiled the official “Ethereum for Institutions” website to guide enterprises, builders, and institutions in adopting Ethereum. Managed by the Foundation’s Enterprise Acceleration Team, the site emphasizes Ethereum’s role as a core infrastructure layer for global financial transactions. With over 1.1 million validators securing the network, the platform underpins billions in asset management and transaction volume through institutional partners like BlackRock, Visa, eToro, and Coinbase.

Scaling Institutional Adoption Through L2 and Innovation
The website showcases Ethereum’s $50 billion L2 ecosystem, demonstrating the network’s ability to scale for enterprise usage while maintaining decentralization and security. Innovations in privacy and compliance, including ZK proofs, fully homomorphic encryption (FHE), and Trusted Execution Environments (TEEs), offer enterprises tools for regulatory alignment and secure operations. These features position Ethereum as a preferred infrastructure for institutional DeFi, payments, and enterprise-grade blockchain solutions.

The Foundation emphasizes institutional-grade products and integrations, highlighting how Layer 2 networks enable faster transaction throughput and lower fees without compromising security. Enterprises can leverage L2 solutions for high-volume operations, while developers gain guidance on deploying decentralized applications and smart contracts optimized for large-scale usage. This ecosystem expansion signals Ethereum’s readiness to support corporate and institutional blockchain adoption globally.

Beyond technical infrastructure, the platform features case studies and analytics on how enterprises have utilized Ethereum to transform payments, trading, and financial workflows. By connecting blockchain technology with enterprise needs, the Foundation fosters confidence among investors and institutions, demonstrating how Ethereum can facilitate scalable, compliant, and innovative financial applications.

With the new site, the Ethereum Foundation aims to accelerate mainstream institutional engagement, helping organizations navigate complex regulatory environments while leveraging blockchain for operational efficiency. The initiative marks a strategic push to position Ethereum as the leading institutional blockchain network, highlighting its transformative potential for the global financial system.

TL;DR

Companies hold more than 4% of the total Ethereum supply.
BitMine owns 3.31 million ETH after increasing its holdings by 25%.
Corporate reserves of Bitcoin and Solana show slower growth.

Corporate holdings of Ethereum have now surpassed the four percent threshold of its total supply. This level of accumulation exceeds the proportional treasury reserves for both Bitcoin and Solana. Data indicates that seventy distinct entities now control more than six million ETH. BitMine maintains the largest single corporate reserve, holding 3.31 million tokens.

Their acquisition of Ethereum has accelerated throughout October. In contrast, corporate purchasing activity for Bitcoin and Solana has slowed during the same period. For Bitcoin, corporate treasuries hold approximately 3.6 percent of the total supply. Solana corporate reserves account for 2.7 percent of its supply.

Corporate Strategy Shifts Toward Ethereum
The composition of these Ethereum holdings varies. Some entities retain allocations from initial coin offerings conducted years ago. Others represent new purchases executed with corporate capital. BitMine increased its own Ethereum holdings by twenty-five percent in the last month. This aggressive accumulation strategy places the company on a path to control five percent of the entire ETH supply.

The utility of Ethereum reserves differs from the more passive holding strategy common with Bitcoin. Companies like BitMine and SharpLink have announced plans to integrate these assets into decentralized finance protocols. Potential use cases include staking and liquid staking to generate yield. This approach treats the digital asset as a productive holding rather than a static investment.

Meanwhile, the stock market valuation for these treasury companies has stabilized. Most firms now trade at a market price that closely matches the underlying value of their digital asset holdings. This normalization follows a period of heightened speculation earlier in the year. The current trend suggests a maturing sector where corporate digital asset management is becoming an established financial practice.

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

Following the slight pullback in Bitcoin’s price from the $115,000 level, several on-chain metrics are beginning to flash warning signals, and a possible shift in the current market trend. One of these crucial metrics is the Bitcoin Short-Term Holders SOPR.

Rising Bitcoin STH SOPR Signals Warning
Amid fluctuating market action, Bitcoin Short-Term Holders’ Spent Output Profit Ratio (SOPR) is showing that these investors are approaching a crucial point. In a recent quick-take post on the CryptoQuant platform, Yonsei Dent, a market expert, outlined that the key metric is drawing close to the upper band.

BTC STH-SOPR indicator shows the on-chain breakeven threshold for short-term holders. It is worth noting that when the value is more than 1.0, it indicates that these investors are generally making profits. On the other hand, when the metric drops below the 1.0 level, it suggests that the investors are realizing losses.

Given that the Bitcoin short-term holder SOPR hints at the aggregated action of a large number of market players, the metric also has a strong statistical aspect. About 95% of all data points are typically captured by the ±2 standard deviation range. Therefore, a move above that range takes place less than 5% of the time, which makes this trend an uncommon event.

BTC STH SOPR nearing a critical junction | Source: Chart from CryptoQuant on X
Using a combination of the Bollinger Band setup and the short-term holder SOPR, Yonsei Dent highlighted that a steady move to +2σ usually signals resistance or profit-taking zones. Meanwhile, when it is approaching -2σ, it often suggests support or accumulation opportunities.

However, the STH SOPR currently still has some room before reaching the +2σ upper band. While the metric moves closer to the upper band, Dent has underlined the importance of monitoring the indicator to confirm whether momentum has begun to turn or if short-term overheating is gradually appearing.

BTC Has Not Yet Reached Its Top
Despite the potential profit-taking from short-term holders, Joao Wedson, the founder of Alphractal, claims Bitcoin is yet to reach its top for this cycle due to past cycles’ trend. Unlike past cycles, few investors were observed buying the top out of euphoria during a similar period.

In previous ATHs, Bitcoin would spike with pure enthusiasm and then plummet just as quickly, barely having time to breathe above new highs. As a result, thousands of investors were stuck at the top, where their profits turned into losses within days. However, recent trends show that this cycle could be charting a different course.

After reclaiming the $100,000 landmark, BTC appears to have spent almost 1 year holding above this critical area. During the period, the flagship asset has been consolidating and steadily testing a range that would likely be a pure mania in past cycles. 

In a shocking twist, Wedson highlighted that the real euphoria has not yet kicked off. At this point, the expert is uncertain whether it will happen this cycle or the true top is still ahead, noting that euphoria came before consolidation in previous cycles. However, it appears that euphoria was preceded by consolidation, which changes everything this time.

BTC trading at $113,421 on the 1D chart | Source: BTCUSDT on Tradingview.com
Featured image from Pixabay, chart from Tradingview.com

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

TL;DR

Deutsche Digital Assets and Safello have launched the Safello Bittensor Staked TAO ETP (STAO), a product listed on the SIX Swiss Exchange.
The ETP is fully backed by TAO tokens and automatically reinvests staking rewards into its net asset value.
Bittensor has surged 42.35% in October and is trading near $427, with a market capitalization of $4.35 billion.

Deutsche Digital Assets and Safello have launched the Safello Bittensor Staked TAO ETP (STAO), an exchange-traded product offering exposure to Bittensor (TAO), a blockchain that combines decentralized artificial intelligence and open-source machine learning.

The ETP will begin trading on the SIX Swiss Exchange under the ticker STAO. It is fully backed by TAO held in cold wallets and allows investors to earn staking rewards automatically reinvested into the NAV, generating compound growth.

STAO tracks a total return index, the Kaiko Safello Staked Bittensor Index (KSSTAO Index), and applies a maximum management fee of 1.49%. It combines TAO’s price performance with additional staking income, providing institutional investors with a transparent and secure structure to diversify their portfolios.

Deutsche Digital Assets contributes its white-label platform, enabling Safello to leverage its regulatory infrastructure, index management, and exchange listing capabilities, ensuring compliance and robust index tracking. Bittensor exemplifies how decentralized AI and blockchain technology can merge to create value.

Uptober for Bittensor
There is growing demand for assets that integrate DeFi and artificial intelligence under institutional-grade standards. This new ETP gives investors access to staking yields and the potential of an integrated ecosystem within the protection of traditional financial infrastructure.

Bittensor (TAO) has shown strong performance in October, rising 42.35% to $427.59. Its market capitalization has reached $4.35 billion, with a fully diluted valuation of $8.97 billion, positioning it among the top 30 crypto assets by market cap. Trading volume over the past 24 hours is around $408 million.

STAO merges blockchain technology, artificial intelligence, and DeFi tools in a regulated ETP, offering investors an instrument that integrates staking, yield generation, and compliance — setting a new standard for the next generation of crypto investment products in Europe.

Circle Internet Financial Ltd. (NYSE:CRCL) is down over 2% to $133 on Wednesday, but a recent report indicates Circle’s USDC (CRYPTO: USDC) stablecoin has benefited from the GENIUS Act.

USDC Outpaces Tether Under Trump's Policy ShiftAccording to data compiled by Protos, the market capitalization of USDC jumped by 59% since Donald Trump took office, outpacing the 32.5% growth of Tether's USDT (CRYPTO: USDT).

In absolute terms, USDT’s market capitalization climbed from $138 billion to $183 billion, while USDC rose from $48 billion to $76 billion.

The GENIUS Act, introduced earlier in the term, aims to favor U.S.-regulated stablecoin issuers over offshore competitors like Tether.

Though not newly enacted, the policy's ongoing implementation has reinforced expectations that Circle could see long-term benefits.

Circle Gains Edge From Domestic RegulationCircle's U.S. base gives it a compliance advantage after the new law curtailed offshore competition. 

Tether, headquartered in El Salvador, announced plans to create a U.S. subsidiary under Bo Hines, Trump's former digital-asset adviser.

Meanwhile, Circle's major investor Coinbase Global Inc. (NASDAQ:COIN) stands to benefit from both higher USDC volumes and policy clarity.

Trump's regulatory backing reinforces the administration's pro-digital-asset stance following its earlier approval of U.S.-based Bitcoin ETFs.

CRCL Technical Chart Hints At Pending Breakout

CRCL Price Dynamics (Source: TradingView)

Circle's stock trades within a descending channel since June but shows compression near $134. 

The equity is testing clustered exponential moving averages between $135 and $140. 

A breakout above this zone would confirm bullish momentum  and open a move toward the 200-day EMA near $154.80.

Above $157, the next technical projection targets $298, representing the measured move from the long-term channel breakout.

The RSI, now near 49, has recovered from oversold conditions, signaling potential upside if price holds above $140.

Support remains firm at $130–$134. Losing this area would keep CRCL inside its bearish channel, exposing $120 and possibly $100.

Why It MattersTrump's GENIUS Act is more than just a stablecoin law. 

It rewires the balance of power between offshore giants like Tether and U.S.-regulated Circle. 

For the first time, a sitting U.S. administration has given one issuer a structural edge over another in a multi-trillion-dollar liquidity race. 

This isn't only about USDC's 59% growth — it's about whether U.S. policy is quietly building a "digital dollar" through the private sector, with Circle as the chosen vehicle.

Read Next:

Bitcoin At $113,000 As Jerome Powell Faces Crucial Decision At Fed Meeting
Image: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Jazz Pharmaceuticals (JAZZ - Free Report) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on November 5. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis drugmaker is expected to post quarterly earnings of $5.72 per share in its upcoming report, which represents a year-over-year change of -13.5%.

Revenues are expected to be $1.1 billion, up 4.5% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.14% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Jazz?For Jazz, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -7.15%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that Jazz will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Jazz would post a loss of$6.12 per share when it actually produced a loss of -$8.25, delivering a surprise of -34.80%.

Over the last four quarters, the company has beaten consensus EPS estimates two times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Jazz doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

An Industry Player's Expected ResultsAmong the stocks in the Zacks Medical - Biomedical and Genetics industry, Harmony Biosciences Holdings, Inc. (HRMY - Free Report) , is soon expected to post earnings of $0.92 per share for the quarter ended September 2025. This estimate indicates a year-over-year change of +16.5%. This quarter's revenue is expected to be $228.95 million, up 23.1% from the year-ago quarter.

Over the last 30 days, the consensus EPS estimate for Harmony Biosciences has been revised 1.2% up to the current level. Nevertheless, the company now has an Earnings ESP of +28.82%, reflecting a higher Most Accurate Estimate.

This Earnings ESP, combined with its Zacks Rank #3 (Hold), suggests that Harmony Biosciences will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Wall Street expects a year-over-year increase in earnings on higher revenues when HubSpot (HUBS - Free Report) reports results for the quarter ended September 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The earnings report, which is expected to be released on November 5, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis cloud-based marketing and sales software platform is expected to post quarterly earnings of $2.58 per share in its upcoming report, which represents a year-over-year change of +18.4%.

Revenues are expected to be $786.26 million, up 17.4% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.48% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for HubSpot?For HubSpot, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.23%.

On the other hand, the stock currently carries a Zacks Rank of #4.

So, this combination makes it difficult to conclusively predict that HubSpot will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that HubSpot would post earnings of $2.12 per share when it actually produced earnings of $2.19, delivering a surprise of +3.30%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

HubSpot doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Expected Results of an Industry PlayerAstera Labs, Inc. (ALAB - Free Report) , another stock in the Zacks Internet - Software industry, is expected to report earnings per share of $0.39 for the quarter ended September 2025. This estimate points to a year-over-year change of +69.6%. Revenues for the quarter are expected to be $206.73 million, up 82.8% from the year-ago quarter.

The consensus EPS estimate for Astera Labs, Inc. has remained unchanged over the last 30 days. However, an equal Most Accurate Estimate has resulted in an Earnings ESP of 0.00%.

This Earnings ESP, combined with its Zacks Rank #3 (Hold), makes it difficult to conclusively predict that Astera Labs, Inc. will beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Wall Street expects a year-over-year decline in earnings on higher revenues when Acushnet (GOLF - Free Report) reports results for the quarter ended September 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The earnings report, which is expected to be released on November 5, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis golf products maker is expected to post quarterly earnings of $0.88 per share in its upcoming report, which represents a year-over-year change of -1.1%.

Revenues are expected to be $630.76 million, up 1.7% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 5.66% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Acushnet?For Acushnet, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -3.88%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that Acushnet will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Acushnet would post earnings of $1.33 per share when it actually produced earnings of $1.25, delivering a surprise of -6.02%.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Acushnet doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Geron (GERN - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The earnings report, which is expected to be released on November 5, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis drugmaker is expected to post quarterly loss of $0.03 per share in its upcoming report, which represents a year-over-year change of +25%.

Revenues are expected to be $52.49 million, up 85.7% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 7.69% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Geron?For Geron, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -32.35%.

On the other hand, the stock currently carries a Zacks Rank of #4.

So, this combination makes it difficult to conclusively predict that Geron will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Geron would post a loss of$0.03 per share when it actually produced a loss of -$0.02, delivering a surprise of +33.33%.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Geron doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Expected Results of an Industry PlayerAmong the stocks in the Zacks Medical - Biomedical and Genetics industry, Ultragenyx (RARE - Free Report) , is soon expected to post loss of $1.23 per share for the quarter ended September 2025. This estimate indicates a year-over-year change of +12.1%. This quarter's revenue is expected to be $167.55 million, up 20.1% from the year-ago quarter.

The consensus EPS estimate for Ultragenyx has been revised 0.4% lower over the last 30 days to the current level. However, a lower Most Accurate Estimate has resulted in an Earnings ESP of -12.47%.

This Earnings ESP, combined with its Zacks Rank #3 (Hold), makes it difficult to conclusively predict that Ultragenyx will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates two times.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

LOS ANGELES, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zions Bancorporation, N.A. (“Zions Bancorp” or “the Company”) (NASDAQ: ZION) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Zions Bancorp is the subject of a report published by Bloomberg on October 16, 2025, titled: “Zions, Western Alliance Banks Disclose Bad Loans Tied to Alleged Fraud.” According to the report, “Shares of two regional US banks tumbled Thursday after the companies said they were the victims of fraud on loans to funds that invest in distressed commercial mortgages, fueling concern that more cracks are emerging in the credit markets.” Based on this news, shares of Zions Bancorp fell by more than 13.1% on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm 
Brian Schall, Esq. 
310-301-3335
[email protected]

www.schallfirm.com

Fair Isaac (FICO - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The earnings report, which is expected to be released on November 5, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis financial services company is expected to post quarterly earnings of $7.34 per share in its upcoming report, which represents a year-over-year change of +12.2%.

Revenues are expected to be $511.78 million, up 12.8% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 2.7% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Fair Isaac?For Fair Isaac, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.46%.

On the other hand, the stock currently carries a Zacks Rank of #1.

So, this combination indicates that Fair Isaac will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Fair Isaac would post earnings of $7.73 per share when it actually produced earnings of $8.57, delivering a surprise of +10.87%.

Over the last four quarters, the company has beaten consensus EPS estimates two times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Fair Isaac appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

An Industry Player's Expected ResultsAnother stock from the Zacks Computers - IT Services industry, Leidos (LDOS - Free Report) , is soon expected to post earnings of $2.61 per share for the quarter ended September 2025. This estimate indicates a year-over-year change of -10.9%. Revenues for the quarter are expected to be $4.27 billion, up 1.8% from the year-ago quarter.

Over the last 30 days, the consensus EPS estimate for Leidos has been revised 0.3% up to the current level. Nevertheless, the company now has an Earnings ESP of -2.30%, reflecting a lower Most Accurate Estimate.

When combined with a Zacks Rank of #3 (Hold), this Earnings ESP makes it difficult to conclusively predict that Leidos will beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Elanco Animal Health Incorporated (ELAN - Free Report) is expected to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The earnings report, which is expected to be released on November 5, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis company is expected to post quarterly earnings of $0.13 per share in its upcoming report, which represents no change from the year-ago quarter.

Revenues are expected to be $1.09 billion, up 5.9% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 2.15% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Elanco Animal Health?For Elanco Animal Health, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -5.88%.

On the other hand, the stock currently carries a Zacks Rank of #2.

So, this combination makes it difficult to conclusively predict that Elanco Animal Health will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Elanco Animal Health would post earnings of $0.2 per share when it actually produced earnings of $0.26, delivering a surprise of +30.00%.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Elanco Animal Health doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when Evolus, Inc. (EOLS - Free Report) reports results for the quarter ended September 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on November 5. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis company is expected to post quarterly loss of $0.19 per share in its upcoming report, which represents no change from the year-ago quarter.

Revenues are expected to be $67.82 million, up 11% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Evolus?For Evolus, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -2.70%.

On the other hand, the stock currently carries a Zacks Rank of #2.

So, this combination makes it difficult to conclusively predict that Evolus will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Evolus would post a loss of$0.09 per share when it actually produced a loss of -$0.24, delivering a surprise of -166.67%.

The company has not been able to beat consensus EPS estimates in any of the last four quarters.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Evolus doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Expected Results of an Industry PlayerCeriBell, Inc. (CBLL - Free Report) , another stock in the Zacks Medical - Products industry, is expected to report loss per share of $0.43 for the quarter ended September 2025. This estimate points to a year-over-year change of +76.8%. Revenues for the quarter are expected to be $21.79 million, up 26.8% from the year-ago quarter.

The consensus EPS estimate for CeriBell, Inc. has been revised 2.3% higher over the last 30 days to the current level. However, a higher Most Accurate Estimate has resulted in an Earnings ESP of +6.10%.

When combined with a Zacks Rank of #3 (Hold), this Earnings ESP indicates that CeriBell, Inc. will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates two times.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

electroCore, Inc. (ECOR - Free Report) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on November 5. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis company is expected to post quarterly loss of $0.36 per share in its upcoming report, which represents a year-over-year change of -16.1%.

Revenues are expected to be $7.85 million, up 19.9% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 4.08% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for electroCore?For electroCore, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -1.41%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that electroCore will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that electroCore would post a loss of$0.32 per share when it actually produced a loss of -$0.35, delivering a surprise of -9.38%.

Over the last four quarters, the company has beaten consensus EPS estimates just once.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

electroCore doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Expected Results of an Industry PlayerAmong the stocks in the Zacks Medical - Drugs industry, Madrigal (MDGL - Free Report) , is soon expected to post loss of $1.99 per share for the quarter ended September 2025. This estimate indicates a year-over-year change of +59.6%. This quarter's revenue is expected to be $249.15 million, up 300.8% from the year-ago quarter.

The consensus EPS estimate for Madrigal has been revised 29.2% higher over the last 30 days to the current level. However, a higher Most Accurate Estimate has resulted in an Earnings ESP of +27.84%.

When combined with a Zacks Rank of #2 (Buy), this Earnings ESP indicates that Madrigal will most likely beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

The market expects Clearwater Analytics (CWAN - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on November 5. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis automated investment accounting software developer is expected to post quarterly earnings of $0.15 per share in its upcoming report, which represents a year-over-year change of +25%.

Revenues are expected to be $203.84 million, up 76% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 10.35% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Clearwater Analytics?For Clearwater Analytics, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -14.47%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that Clearwater Analytics will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Clearwater Analytics would post earnings of $0.13 per share when it actually produced earnings of $0.12, delivering a surprise of -7.69%.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Clearwater Analytics doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Expected Results of an Industry PlayerFlywire (FLYW - Free Report) , another stock in the Zacks Internet - Software industry, is expected to report earnings per share of $0.19 for the quarter ended September 2025. This estimate points to a year-over-year change of -36.7%. Revenues for the quarter are expected to be $179.54 million, up 18.6% from the year-ago quarter.

The consensus EPS estimate for Flywire has been revised 500% lower over the last 30 days to the current level. However, a higher Most Accurate Estimate has resulted in an Earnings ESP of +29.23%.

When combined with a Zacks Rank of #3 (Hold), this Earnings ESP indicates that Flywire will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed EPS estimates just once.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

The market expects Cytokinetics (CYTK - Free Report) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The earnings report, which is expected to be released on November 5, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis biopharmaceutical company is expected to post quarterly loss of $1.59 per share in its upcoming report, which represents a year-over-year change of -16.9%.

Revenues are expected to be $5.56 million, up 1108.7% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.21% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Cytokinetics?For Cytokinetics, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -5.53%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that Cytokinetics will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Cytokinetics would post a loss of$1.34 per share when it actually produced a loss of -$1.12, delivering a surprise of +16.42%.

Over the last four quarters, the company has beaten consensus EPS estimates two times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Cytokinetics doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Expected Results of an Industry PlayerAmong the stocks in the Zacks Medical - Biomedical and Genetics industry, Qiagen (QGEN - Free Report) , is soon expected to post earnings of $0.58 per share for the quarter ended September 2025. This estimate indicates a year-over-year change of -1.7%. This quarter's revenue is expected to be $525.99 million, up 4.8% from the year-ago quarter.

The consensus EPS estimate for Qiagen has been revised 0.7% lower over the last 30 days to the current level. However, a lower Most Accurate Estimate has resulted in an Earnings ESP of -0.73%.

This Earnings ESP, combined with its Zacks Rank #3 (Hold), makes it difficult to conclusively predict that Qiagen will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates two times.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Woori Financial Group Inc. (WF) Q3 2025 Earnings Call October 29, 2025 3:00 AM EDT

Company Participants

Hong Sung Han - Head of IR
Sung-Wook Lee - Vice President of Finance Section
Jang-Geun Park - C.R.O
Il-Jin Oak

Conference Call Participants

Jun-Sup Jung - NH Investment & Securities Co., Ltd., Research Division
Doosan Baek - Korea Investment & Securities Co., Ltd., Research Division
Do Ha Kim - Hanwha Investment & Securities Co., Ltd., Research Division
Jaewoong Won - HSBC Global Investment Research
Tae Joon Jeong - Mirae Asset Securities Co., Ltd., Research Division
Hye-jin Park - Daishin Securities Co. Ltd., Research Division

Presentation

Hong Sung Han
Head of IR

Good afternoon. I am Han Hong Sung, Head of IR at Woori Financial Group. Let me first begin by thanking everyone for taking time to participate in this earnings call for Woori Financial Group.

On today's call, we have the group CFO, Lee Sung-Wook; Group CDO, Oak Il-Jin; and the group's Risk Management division, Senior General Manager, Park Jang-Geun on the call. On today's call, the group CFO, Lee Sung-Wook, will give a presentation on the earnings performance. After which, we will have a Q&A session. Please note that the earnings call is being conducted with simultaneous interpretation for our overseas investors.

Now let us start our presentation on Woori Financial Group's Earnings for the Third Quarter of 2025.

Sung-Wook Lee
Vice President of Finance Section

Good afternoon. This is Lee Sung-Wook, the CFO of Woori Financial Group. Let me go over the third quarter performance for 2025. I do have a cold, so please understand if my voice is a bit rough, and please turn to Page 3 of the presentation material that has been disclosed on our website.

First, let me discuss net income. Woori Financial Group's year-to-date net income as of the third quarter end was up

Recommended For You

Key Takeaways Halliburton signed a framework deal with Shell for umbilical-less tubing hanger operations.ROCS technology cuts deck operations by up to 75%, improving safety and efficiency offshore.Successful Gulf of America trials proved ROCS as a reliable deepwater completion solution.
Halliburton (HAL - Free Report) , a Houston, TX-based oil and gas equipment and services company, has significantly advanced deepwater operations with the introduction of its Remote Operated Controls Systems (“ROCS”) technology, signing a strategic framework agreement with Shell plc (SHEL - Free Report) for umbilical-less tubing hanger installation and retrieval services. This collaboration highlights a paradigm shift in the offshore energy HAL Quick QuoteHAL - Free Report) ,%20a%20Houston,%20TX-based%20oil%20and%20gas%20equipment%20and%20services%20company,%20has%20significantly%20advanced%20deepwater%20operations%20with%20the%20introduction%20of%20its%20Remote%20Operated%20Controls%20Systems%20(">sector, offering a transformative solution that enhances both the safety and efficiency of complex deepwater operations.

With the recent success of ROCS in the Gulf of America, the technology is set to revolutionize how oil and gas companies approach well-completion challenges in harsh and remote deepwater environments.

Game-Changer in Deepwater OperationsThe ROCS technology, developed by Optime, a Halliburton service, has garnered significant attention for its ability to outperform traditional hydraulic systems used in deepwater well-completion procedures. Unlike conventional systems that rely heavily on hydraulic umbilicals, ROCS is a compact and umbilical-less control system, offering a safer and more efficient alternative. By eliminating the need for bulky umbilical connections, ROCS reduces surface pressure risks, decreases personnel exposure to hazardous environments and streamlines operations, making it an ideal solution for operators working in challenging offshore locations.

The success of ROCS is particularly evident in its recent achievement of setting a global benchmark with the installation of a tubing hanger at a staggering 8,458 feet — marking the deepest umbilical-less operation in history. Deployed across various regions, including the Norwegian Continental Shelf, West Africa and the Gulf of America, ROCS has demonstrated its reliability and effectiveness in the most demanding environments.

Efficiency and Safety: The Hallmarks of ROCS TechnologyOne of the key features of ROCS technology is its ability to accelerate running-in and pulling-out-of-hole procedures, significantly improving the speed and efficiency of well-completion operations. Compared with traditional methods, ROCS reduces deck operations by up to 75%, offering a more streamlined approach to well construction. This reduction in time and resources not only leads to cost savings but also enhances the overall safety of the operation by minimizing exposure to potential risks on the rig.

Furthermore, ROCS improves downhole line tests, ensuring more accurate results and enabling operators to make quicker and more informed decisions. By utilizing remote-operated controls, operators can perform complex operations without the need for extensive manual intervention, thereby reducing the likelihood of human error and enhancing operational safety.

Proven Performance of ROCS in Complex Deepwater EnvironmentsROCS has been deployed in a variety of challenging deepwater environments, demonstrating consistent performance and reliability. The technology's adaptability to different regions, such as the Norwegian Continental Shelf, West Africa and the Gulf of America, underscores its versatility and robustness. It has proven effective in both shallow and ultra-deepwater wells, providing operators with a flexible and scalable solution to meet the demands of diverse offshore projects.

In the Gulf of America, the successful completion of a three-well technology phase highlighted ROCS' potential to deliver faster, safer and more cost-effective well-completion solutions. This successful phase of testing not only validated ROCS as a viable alternative to traditional hydraulic methods but also showcased its ability to perform in deepwater conditions where other technologies have often struggled.

ROCS: The Future of Deepwater Well-CompletionAs deepwater exploration and production continue to evolve, the demand for more efficient, safe and reliable technologies is greater than ever. ROCS, with its proven performance and cutting-edge capabilities, is well-positioned to meet these needs. The agreement between Halliburton and Shell marks a significant milestone in the adoption of ROCS technology across the global offshore drilling fleet. With the speed, precision and cost-effectiveness, ROCS is not just an innovation; it is the future of well-completion in complex environments.

As the industry moves toward more sustainable and efficient energy solutions, ROCS represents a key step in reshaping how oil and gas companies approach well construction and completion in deepwater environments. Its proven track record, coupled with the ability to improve both operational efficiency and safety, makes ROCS a vital tool for modern offshore energy projects.

Conclusion: The Impact of ROCS on the Offshore IndustryHalliburton’s strategic partnership with a London-based integrated oil and gas company to implement ROCS technology underscores the growing shift toward more efficient, cost-effective and safer operations in the offshore drilling sector. The benefits of ROCS — ranging from reduced deck operations to improved downhole line testing — make it an invaluable asset for operators working in complex, deepwater environments. As global rig fleets continue to adopt this advanced technology, ROCS is poised to become the standard in deepwater well-completion operations, setting a new benchmark for safety, efficiency and reliability in the offshore energy industry.

HAL's Zacks Rank & Key PicksCurrently, HAL and SHEL have a Zacks Rank #3 (Hold) each.

Investors interested in the energy sector might look at some better-ranked stocks like Canadian Natural Resources Limited (CNQ - Free Report) and Cheniere Energy (LNG - Free Report) , currently sporting a Zacks Rank #1 (Strong Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.

Canadian Natural is one of Canada's largest independent oil and natural gas producers, with operations spanning exploration, development and production across North America, the North Sea and Offshore Africa. The company focuses on a diversified portfolio of assets, including oil sands, conventional crude oil, natural gas and thermal in-situ operations. Canadian Natural is valued at $65.74 billion.  

Cheniere Energy is a leading U.S. energy company focused on liquefied natural gas (“LNG”) production and export. Through its advanced infrastructure and facilities, Cheniere Energy plays a crucial role in the global LNG market, contributing to energy security and the transition to cleaner energy. Cheniere Energy is valued at $48.31 billion.  

TL;DR

Aptos attracted more than $545 million in stablecoin inflows in 24 hours, surpassing Ethereum and Solana and showing strong on-chain engagement.
Daily active users on Aptos recently climbed to 1.8 million, well above Ethereum and Solana activity levels, reinforcing the network’s growing participation.
The stablecoin market is above $300 billion in total supply, with Aptos increasingly positioned as a competitive hub for fast and low-fee settlement.

Aptos has taken the spotlight after drawing over $545 million in stablecoin inflows within a single day, a level not seen on most Layer 1 networks this year. The activity pushed Aptos ahead of Ethereum and Solana in daily stablecoin supply growth, suggesting that users and capital are increasingly exploring alternative chains for efficiency, scalability, and developer-friendly environments. Market data also shows the Aptos network edging toward a more influential role in global digital payments as stablecoins continue expanding into mainstream finance.

At present, Aptos holds over $1 billion in stablecoins circulating on its chain. Ethereum still dominates in total value and ecosystem depth, yet the speed and low-fee performance of Aptos appears to be gaining traction among developers building payment and DeFi applications. The number of daily active users on Aptos reached 1.8 million, compared to around half a million on Ethereum and slightly above that on Solana.

Growing Stablecoin Adoption And Global Payment Expansion
New research from a16zcrypto highlights that the total stablecoin supply has surpassed $300 billion for the first time, reflecting a shift toward digital-native settlement rails. Analysts from Keyrock and Bitso expect stablecoins to represent 12 percent of global payment flows by 2030, including remittances across Latin America, Asia, and Africa. That projection suggests a future where stablecoins rival traditional money transfer services, especially as cross-border transactions increasingly move to blockchain networks with real-time settlement.

New Catalysts Arrive On The Aptos Network
Part of the renewed curiosity surrounding Aptos stems from the launch of Donald Trump’s USD1 stablecoin on the chain this month. The asset is built using Aptos’ Move language and is already gaining traction among DeFi protocols in the ecosystem, including Hyperion, Thala Labs, and Panora Exchange. The project positions Aptos as a testing ground for consumer-facing financial products designed to merge traditional finance with blockchain-based infrastructure.

APT is trading near $3.35, slightly lower this week. Despite market turbulence, the network’s rise in usage, developer interest, and stablecoin expansion suggests that Aptos is carving out a growing role within the multi-chain economy, especially for payments and high-speed settlement.

XRP (CRYPTO: XRP) is seeing strong growth across key metrics, according to a new report by analytics firm Messari.

What Happened: XRP ended Q3 as the fourth-largest cryptocurrency, recording an all-time high market cap of $170.3 billion (+29% QoQ) and a price of $2.85 (+29% QoQ), the report stated.

Circulating supply rose 1.4%, while market cap jumped 392.6% year-over-year.

Transaction fees fell 24.5% QoQ to $513,900 and burned XRP dropped 43.6% to 174,200 XRP.

To date, around 14.2 million XRP has been burned, while 1 billion XRP continues to be released monthly from escrow.

Ripple's USD-pegged stablecoin RLUSD grew 34.7% QoQ to a market cap of $88.8 million, making it the XRPL's largest stablecoin.

Meanwhile, real-world asset (RWA) issuance surged, pushing the XRPL's RWA market cap to an all-time high of $364.2 million (+215% QoQ).

Also Read: XRP Gains 7% In 1 Week: What Is Going On?

Why It Matters: Messari reported noted that there are currently seven pending U.S. spot XRP ETF applications, with SEC decisions expected between Oct. 18 and Nov. 14,.

XRP futures listed on Coinbase and CME satisfy the new six-month tracking requirement, fueling expectations for ETF approval by year-end.

Polymarket odds of an ETF approval in 2025 stand at 99%.

Globally, three Canadian XRP ETFs launched in June, and Hashdex introduced the first Brazilian XRP ETF in April.

Following Michael Saylor's Digital Asset Treasury (DAT) model, several companies have announced over $900 million in XRP acquisitions in the U.S., led by Trident Digital ($500 million) and Webus International ($300 million).

Japanese financial giant SBI Holdings reportedly holds over $10 billion in XRP, while Gumi and Vivopower have also made strategic purchases.

What's Next: Analyst Ali Martinez cautioned that XRP's TD Sequential indicator has again flashed a sell signal, after correctly predicting prior reversals, suggesting potential resistance near $2.80 in the short term.

Read Next:

Bitcoin, Ethereum, XRP, Dogecoin Wobble On Wednesday Ahead Of FOMC Meeting
Image: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

TL;DR

The German AfD party has officially proposed creating a national Bitcoin reserve for the state.
The initiative seeks to protect the German economy from the risks of monetary inflation.
Germany would change its strategy of selling Bitcoin to start accumulating it as a reserve.

A political party in Germany has formally proposed establishing a national Bitcoin reserve. The Alternative for Germany party, known as AfD, submitted the motion to parliament. As the second-largest opposition group in the Bundestag, the party seeks to position Bitcoin as protection against inflation risks. The proposal marks a strategic shift toward treating digital assets as sovereign holdings.

The initiative follows Germany’s recent sale of nearly 50,000 Bitcoin seized from criminal operations. Those coins would be worth approximately $6.5 billion at current prices around $113,000. Many cryptocurrency analysts criticized the liquidation as a missed opportunity. Now, the AfD suggests Germany should have retained those assets instead.

From Bitcoin Sales to Strategic Reserves
The motion calls for acquiring Bitcoin representing about two percent of the total supply. This amount would make Germany one of Europe’s largest state holders of cryptocurrency. The proposal frames Bitcoin as a digital equivalent to gold in national reserves. It arrives amid concerns about traditional currency stability and central bank policies.

France shows parallel interest, with lawmaker Éric Ciotti supporting similar reserve plans. This developing situation could initiate a broader European movement toward sovereign Bitcoin holdings. The German finance ministry must evaluate storage security and compliance with European Union financial regulations.

Other governments monitor Germany’s decision process. The outcome might influence how nations approach Bitcoin within their economic strategies. State-level adoption could advance from theoretical discussion to practical implementation.

Key NotesStablecoin issuer Tether has outperformed South Korea and three other countries with $135 billion in US debt.It is the 17th largest holder of the asset, trailing Brazil.Tether recently celebrated reaching 500 million verified users.
Tether CEO Paolo Ardoino took to X to announce that his company is now the 17th-largest holder of United States debt. At this position, the issuer of the largest stablecoin, USDT, has outranked South Korea, the UAE, and Germany, and is already looking to push past Brazil.

Tether Holds $135 Billion in US Treasury
Tether is currently boasting of $135 billion in US debt. Tether first surpassed Germany way back in May this year. It’s worth mentioning that the largest holder of the US Treasury, with way more than $1.1 trillion in assets, is Japan.

With 135 billion of U.S Treasuries, Tether is now the 17th largest holder of U.S debt, passing also South Korea.
Soon Brazil! pic.twitter.com/wUDyvGcSHE

— Paolo Ardoino 🤖 (@paoloardoino) October 29, 2025

This suggests that there is notable progression in Tether’s growth curve momentum. The USDT company’s milestone reflects that a crypto-based entity has surpassed an industrial state in government bonds.

Ultimately, this milestone lends credibility to USDT as it is backed by solid, liquid, and universally recognized assets

Meanwhile, the stablecoin has recorded significant growth in its ecosystem and is already looking at bagging another historic profit figure by the end of this year.

Tether Celebrates Multiple Milestones
During an interview at the Plan B Forum in Lugano, Switzerland, Ardoino shared that Tether expects its net profits to hit nearly $15 billion in 2025. In previous years, the company has seen such huge profits.

In 2024, it posted over $13 billion in net profit, and this was more than double its $6.2 billion from 2023. Whenever it records such outstanding returns, Tether’s low costs and Treasury-backed model are highlighted as key to its margins. Up to the time of this writing, USDT still maintains a dominant share of the stablecoin market.

Recently, it celebrated the milestone of reaching 500 million verified users among other achievements. Beyond USDT, the Tether ecosystem is moving at a fast pace. Earlier this October, its gold-backed token, XAUt, officially surpassed $1 billion in market value. This feat

was driven by gold reaching an All-time High (ATH) price at the time.

Disclaimer: Coinspeaker is committed to providing unbiased and transparent reporting. This article aims to deliver accurate and timely information but should not be taken as financial or investment advice. Since market conditions can change rapidly, we encourage you to verify information on your own and consult with a professional before making any decisions based on this content.

Tether (USDT) News, Cryptocurrency News, News

Benjamin Godfrey is a blockchain enthusiast and journalist who relishes writing about the real life applications of blockchain technology and innovations to drive general acceptance and worldwide integration of the emerging technology. His desire to educate people about cryptocurrencies inspires his contributions to renowned blockchain media and sites.

Godfrey Benjamin on X

Deutsche Digital Assets (DDA), a European crypto asset manager, has teamed up with Safello, the Nordic cryptocurrency exchange, to launch the Safello Bittensor Staked TAO exchange traded product (ETP).